5 results match your criteria: "Lyon Croix Rousse Hospital[Affiliation]"
J Craniofac Surg
August 2025
Department of MaxilloFacial Surgery, Lyon Croix Rousse Hospital, Lyon, France.
Anterior open bite is a frequent occlusal disorder that affects chewing, swallowing, speech, tooth loss, and aesthetics. Persistent infantile swallowing is a major cause of occurrence and relapse of anterior open bite after treatment. This retrospective cohort study aimed to identify factors affecting postsurgical relapse.
View Article and Find Full Text PDFBiomed Res Int
September 2024
Research on Healthcare Performance (RESHAPE) Université Claude Bernard Lyon 1, Lyon, France.
Int J Surg Case Rep
April 2024
Maxillofacial Surgery Department, Lyon Croix Rousse Hospital, 103 Grande rue de la Croix Rousse, 69004 Lyon, France.
Introduction And Importance: Cricothyroidotomy is often the last resort when conventional ventilation devices prove ineffective. The conventional procedure that involves several steps and requires the completion of a preoperative checklist. This report describes a novel approach to cricothyroidotomy, allowing quick access to the cricothyroid membrane in fewer steps.
View Article and Find Full Text PDFEmerg Microbes Infect
December 2024
Immunogenomics and Inflammation Research Team, University of Lyon, Edouard Herriot Hospital, Lyon, France.
Serological studies of COVID-19 convalescent patients have identified polyclonal lineage-specific and cross-reactive antibodies (Abs), with varying effector functions against virus variants. Individual specificities of anti-SARS-CoV-2 Abs and their impact on infectivity by other variants have been little investigated to date. Here, we dissected at a monoclonal level neutralizing and enhancing Abs elicited by early variants and how they affect infectivity of emerging variants.
View Article and Find Full Text PDFInt J Mol Sci
October 2021
Immunogenomics and Inflammation Research Team, University of Lyon, Edouard Herriot Hospital, 69003 Lyon, France.
Individuals with pre-existing chronic systemic low-grade inflammation are prone to develop severe COVID-19 and stronger anti-SARS-CoV-2 antibody responses. Whether this phenomenon reflects a differential expansion of antiviral B cells or a failure to regulate antibody synthesis remains unknown. Here, we compared the antiviral B cell repertoire of convalescent healthcare personnel to that of hospitalized patients with pre-existing comorbidities.
View Article and Find Full Text PDF